Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for p- glycoprotein 1
Most Correlated Studies
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Most Relevant Literature
- Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Trans…
- Delphinidin induces autophagic flux blockage and apoptosis by inhibiting both multidrug resistance g…
- The methylimidazolium ionic liquid M8OI is a substrate for OCT1 and p-glycoprotein-1 in rat.
- ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
- Optimization of irinotecan chronotherapy with P-glycoprotein inhibition.
Most Relevant Clinical Trials
- Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet
- PET Imaging of P-glycoprotein Function Using [11C]dLop
- Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeut…
- Efavirenz and Ritonavir on Human Brain P-Glycoprotein
- Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
